The DOI matches its Crossref record; 251 of the 254 references it cites were found in a registry or an index.
Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid
Open accessAbstract
The mechanisms by which intestinal bacteria achieve their associated health benefits can be complex and multifaceted. In this respect, the diverse microbial composition of the human gastrointestinal tract (GIT) provides an almost unlimited potential source of bioactive substances (pharmabiotics) which can directly or indirectly affect human health. Bacteriocins and fatty acids are just two examples of pharmabiotic substances which may contribute to probiotic functionality within the mammalian GIT. Bacteriocin production is believed to confer producing strains with a competitive advantage within complex microbial environments as a consequence of their associated antimicrobial activity. This has the potential to enable the establishment and prevalence of producing strains as well as directly inhibiting pathogens within the GIT. Consequently, these antimicrobial peptides and the associated intestinal producing strains may be exploited to beneficially influence microbial populations. Intestinal bacteria are also known to produce a diverse array of health-promoting fatty acids. Indeed, certain strains of intestinal bifidobacteria have been shown to produce conjugated linoleic acid (CLA), a fatty acid which has been associated with a variety of systemic health-promoting effects. Recently, the ability to modulate the fatty acid composition of the liver and adipose tissue of the host upon oral administration of CLA-producing bifidobacteria and lactobacilli was demonstrated in a murine model. Importantly, this implies a potential therapeutic role for probiotics in the treatment of certain metabolic and immunoinflammatory disorders. Such examples serve to highlight the potential contribution of pharmabiotic production to probiotic functionality in relation to human health maintenance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several health benefits have been attributed to CLA, and there is increasing evidence that these effects are isomer-specific [257].”
From Lactic Acid Bacteria in Raw-Milk Cheeses: From Starter Cultures to Probiotic Functions (2022) · cites this paper as [257]
Citations
Cites
Items 201–251 of 251
Mutacin II, a bactericidal antibiotic from Streptococcus mutans
Chikindas, M. L., Novák, J., Driessen, A. J. M., Konings, W. N., Schilling, K., & Caufield, P. W. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2656 · Cited by 58
Comparative Analysis of Chromosome-Encoded Microcins
Poey, M. E., Azpiroz, M. F., & Laviña, M. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1411-1418.2006 · Cited by 58
Probiotics: time for a dose of realism.
Tannock, G. W. (2003) · PubMed · Cited by 57
Destoumieux‐Garzón, D., Péduzzi, J., Thomas, X., Djédiat, C., & Rebuffat, S. (2006) · BioMetals · doi:10.1007/s10534-005-4452-9 · Cited by 55
Screening ofBifidobacterium strains for bacteriocin production
Meghrous, J., Baratte-Euloge, P., Revol‐Junelles, A., Ballongue, J., & Petitdemange, H. (1990) · Biotechnology Letters · doi:10.1007/bf01030755 · Cited by 54
Animal Feeding Strategies for Conjugated Linoleic Acid Enrichment of Milk
a, B. "., a, S., b, D., & a, M. (2003) · AOCS Publishing eBooks · doi:10.1201/9781439822166-9 · Cited by 51
Šmajs, D., & Weinstock, G. M. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.13.3958-3966.2001 · Cited by 49
Kuhar, I., & Žgur‐Bertok, D. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.23.7373-7380.1999 · Cited by 48
Bac 32, a Novel Bacteriocin Widely Disseminated among Clinical Isolates of Enterococcus faecium
Inoue, T., Tomita, H., & Ike, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1202-1212.2006 · Cited by 47
Zihler, A., Gagnon, M., Chassard, C., Hegland, A., Stevens, M. J. A., Braegger, C., & Lacroix, C. (2010) · Microbiology · doi:10.1099/mic.0.042036-0 · Cited by 47
Dairy Fats and Related Products
(2009) · Wiley eBooks · doi:10.1002/9781444316223 · Cited by 47
Colonization of the Human Oral Cavity by a Strain of Streptococcus mutans
Hillman, J. D., Yaphe, B. I., & Johnson, K. P. (1985) · Journal of Dental Research · doi:10.1177/00220345850640110301 · Cited by 44
Mushtaq, S., Mangiapane, E. H., & Hunter, K. A. (2009) · British Journal Of Nutrition · doi:10.1017/s000711450999328x · Cited by 43
Jiménez, E., Martı́n, R., Maldonado‐Barragán, A., Martín, V., de Segura, A. G., Fernández, L., & Rodríguez, J. M. (2010) · Journal of Bacteriology · doi:10.1128/jb.00703-10 · Cited by 42
Prophage induction in Lactococcus lactis by the bacteriocin Lactococcin 972
Madera, C., García, P., Rodrı́guez, A., Suárez, J. E., & Martı́nez, B. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.11.004 · Cited by 41
Synthesis of Trypsin-Resistant Variants of the Listeria -Active Bacteriocin Salivaricin P
O'Shea, E. F., O’Connor, P. M., Cotter, P. D., Ross, R. P., & Hill, C. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.00523-10 · Cited by 40
Incidence of colicinogenic strains among humanEscherichia coli
Šmarda, J., & Obdržálek, V. (2001) · Journal of Basic Microbiology · doi:10.1002/1521-4028(200112)41:6 · Cited by 39
Colicins and their potential in cancer treatment
Lancaster, L. E., Wintermeyer, W., & Rodnina, M. V. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.10.006 · Cited by 39
Majhenič, A. Č., Venema, K., Allison, G. E., Matijašić, B. B., Rogelj, I., & Klaenhammer, T. R. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1424-2 · Cited by 38
Marcille, F., Gómez, A., Joubert, P., Ladiré, M., Veau, G., Clara, A., Gavini, F., Willems, A., & Fons, M. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.7.3424-3431.2002 · Cited by 38
Involvement of Enterobactin Synthesis Pathway in Production of Microcin H47
Azpiroz, M. F., & Laviña, M. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1235-1241.2004 · Cited by 38
Suda, S., Westerbeek, A., O’Connor, P. M., Ross, R. P., Hill, C., & Cotter, P. D. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.08.011 · Cited by 37
Roy, R. S., Allen, O., & Walsh, C. T. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80126-4 · Cited by 37
Evolution of Microcin V and Colicin Ia Plasmids in Escherichia coli
Jeziorowski, A., & Gordon, D. M. (2007) · Journal of Bacteriology · doi:10.1128/jb.00243-07 · Cited by 37
Mathys, S., von Ah, U., Lacroix, C., Staub, E., Mini, R., Cereghetti, T., & Meile, L. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-55 · Cited by 35
Isolation and partial characterization of the Streptococcus mutans type AII lantibiotic mutacin K8
Robson, C. L., Wescombe, P. A., Klesse, N. A., & Tagg, J. R. (2007) · Microbiology · doi:10.1099/mic.0.2006/003756-0 · Cited by 35
Herrmann, J. E., Rubin, D., Häsler, R., Helwig, U., Pfeuffer, M., Auinger, A., Laue, C., Winkler, P., Schreiber, S., BELL, D. E., et al. (2009) · Lipids in Health and Disease · doi:10.1186/1476-511x-8-35 · Cited by 34
Bäckhed, F. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04123.x · Cited by 33
Biéler, S., Silva, F., & Belin, D. (2010) · Research in Microbiology · doi:10.1016/j.resmic.2010.07.003 · Cited by 30
Arakawa, K., Kawai, Y., Ito, Y., Nakamura, K., Chujo, T., Nishimura, J., Kitazawa, H., & Saito, T. T. (2010) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2010.02810.x · Cited by 29
Structure of microcin C51, a new antibiotic with a broad spectrum of activity
Metlitskaya, A. Z., Katrukha, G. S., Shashkov, A. S., Zaitsev, D. A., Egorov, T. A., & Khmel, I. A. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01345-2 · Cited by 29
Boyer, A. E., & Tai, P. C. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.7.1662-1672.1998 · Cited by 28
A lantibiotic gene family widely distributed in Streptococcus salivarius and Streptococcus pyogenes.
Simpson, W. J., Ragland, N. L., Ronson, C. W., & Tagg, J. R. (1995) · PubMed · Cited by 26
Lee, K. (2009) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.0907.07010 · Cited by 25
Cytotoxicity of pyocin S2 to tumor and normal cells and its interaction with cell surfaces
Watanabe, T., & Saito, H. (1980) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(80)90039-2 · Cited by 24
Microcin 15m from Escherichia coli: mechanism of antibiotic action
Aguilar, A., Pérez-Díaz, J. C., Baquero, F., & Asensio, C. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.3.381 · Cited by 24
The Potential of Bacteriocin-Producing Probiotics and Associated Caveats
Gordon, D. M. (2009) · Future Microbiology · doi:10.2217/fmb.09.78 · Cited by 24
Bradley, D., & Howard, S. P. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-12-2721 · Cited by 23
Hennessy, A. A., Ross, R. P., Stanton, C., Devery, R., & Murphy, J. J. (2007) · Elsevier eBooks · doi:10.1533/9781845693107.3.443 · Cited by 20
Edionwe, A. O., & Kies, C. (2001) · Plant Foods for Human Nutrition · doi:10.1023/a:1011136724577 · Cited by 18
Advances in conjugated linoleic acid research, volume 2.
Sébédio, J. L., Christie, W. W., & Adlof, R. O. (2003) · Cited by 18
A biological stabilization technology for peptide drugs: enzymatic introduction of thioether-bridges
Moll, G. N., Kuipers, A., de Vries, L., Bosma, T., & Rink, R. (2009) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2009.03.001 · Cited by 15
The Evolution of Reduced Microbial Killing
Vriezen, J. A. C., Valliere, M., & Riley, M. A. (2009) · Genome Biology and Evolution · doi:10.1093/gbe/evp042 · Cited by 15
Genetic basis for mutacin N and of its relationship to mutacin I.
Jd, H., Balakrishnan, B., & Tagg, J. R. (2004) · PubMed · Cited by 14
The Action of Colicins on Eukaryotic Cells
Šmarda, J. (1983) · Journal of Toxicology Toxin Reviews · doi:10.3109/15569548309006493 · Cited by 13
Duquesne, S., Destoumieux‐Garzón, D., Zirah, S., Knappe, T. A., Goulard, C., Péduzzi, J., Marahiel, M. A., & Rebuffat, S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-73657-0_15 · Cited by 10
Microcin 15n: a second antibiotic from Escherichia coli LP15.
Aguilar, A., Baquero, F., Martínez, J. L., & ASENSIO, C. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.325 · Cited by 10
Effects of temperature and of heat shock on the expression and action of the colicin A lysis protein
Cavard, D. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.17.5189-5192.1995 · Cited by 9
Guri, A. J., Hontecillas, R., & Bassaganya-Riera, J. (2008) · Lifestyle Genomics · doi:10.1159/000112460 · Cited by 6
Microbial Production of Bioactive Metabolites
Mills, S., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2009) · Wiley eBooks · doi:10.1002/9781444316223.ch9 · Cited by 3
Ross, R., Murphy, J., Stanton, C., Devery, R., & Hennessy, A. A. (2007) · CRC Press eBooks · doi:10.1201/9781439823897.ch21 · Cited by 3
Flagged first, then by citations
3 of the 254 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Anand, 1984, Antibacterial activity associated with Bifidobacterium bifidum, Cultured Dairy Products Journal, 2, 6
- Shanahan, 2009, Pharmabiotics: bioactives from mining host-microbe-dietary interactions, Functional Food Reviews, 1, 20
- Zinedine, 2007, Isolation and characterisation of strains of bifidobacteria with probiotic properties in vitro, World Journal of Dairy and Food Science, 2, 28
Cited by
Sorted by citations
Bacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
Probiotic Mechanisms of Action
Bermúdez-Brito, M., Plaza‐Díaz, J., Muñoz‐Quezada, S., Gómez‐Llorente, C., & Gil, Á. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000342079 · Cited by 1,326
Minireview: Gut microbiota: The neglected endocrine organ
Clarke, G., Stilling, R. M., Kennedy, P. J., Stanton, C., Cryan, J. F., & Dinan, T. G. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1108 · Cited by 1,192
Hemarajata, P., & Versalovic, J. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12459294 · Cited by 1,083
Impact of antibiotics on the human microbiome and consequences for host health
Patangia, D. V., Ryan, C. A., Dempsey, E. M., Ross, R. P., & Stanton, C. (2022) · MicrobiologyOpen · doi:10.1002/mbo3.1260 · Cited by 861
Metadata
- Authors
- O'Shea, E. F., Cotter, P. D., Stanton, C., Ross, R. P., & Hill, C.
- Affiliations
- Teagasc - The Irish Agriculture and Food Development Authority (IE)
- University College Cork (IE)
- Corresponding author
- Ross, R. Paul
- Venue
- International Journal of Food Microbiology
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 152
- Issue
- 3
- Pages
- 189-205
- ISSN
- 0168-1605 (ISSN-L)
- OpenAlex
- W2051115786
- Cited by
- 305
- References
- 254
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 16 · 2023: 28 · 2022: 30 · 2021: 21 · 2020: 29 · 2019: 22 · 2018: 25 · 2017: 21 · 2016: 20 · 2015: 22 · 2014: 18 · 2013: 16 · 2012: 10
- FWCI
- 21.42
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- International Journal of Food Microbiology (publishedVersion)
- PubMed (publishedVersion)
- T-Stór (Teagasc) (acceptedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-sa)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Keywords
- probiotics, bacteriocins, conjugated linoleic acid, intestinal bacteria, Bifidobacterium, lactobacilli, antimicrobial peptides, gut microbiota, fatty acid composition, pathogen inhibition
- MeSH terms
- Animals, Bacteriocins, Bifidobacterium, Fatty Acids, Humans, Lactobacillus, Mice, Inbred BALB C, Probiotics, Gastrointestinal Tract, Linoleic Acids, Conjugated, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review